Global Viscosupplementation Market by a CAGR of ~9% During 2023 – 2033

Research Nester published a report titled “Viscosupplementation Market: Global Demand Analysis & Opportunity Outlook 2033” which delivers detailed overview of the global viscosupplementation market in terms of market segmentation by product, application, source, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global viscosupplementation market is anticipated to grow with a CAGR of ~9% over the forecast period, i.e., 2022 – 2031. The market is segmented by application into knee osteoarthritis, shoulder osteoarthritis, hip osteoarthritis, and others. Amongst these, knee osteoarthritis segment is estimated to grow at the highest rate during the forecast period owing to the massively increasing occurrence of knee osteoarthritis worldwide.

The global viscosupplementation market is projected to significantly grow owing to the rising count of obesity in people, followed by worldwide increasing population of aged people, as they majorly face joints and bone related health problems. Furthermore, upsurge in autoimmune disorders, and spiking healthcare investment and increasing merger and acquisitions are some of the major factors anticipated to drive the growth of the market in the forecast period.

Regionally, the global viscosupplementation market is segmented into five major regions comprising of North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the North America region is estimated to witness significant growth over the forecast period owing to the rising inclination of people for short treatment process, escalating occurrence of osteoarthritis, and growing prevalence of aged population in the region.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Worldwide Escalating Geriatric Population to Drive the Market Growth

By 2030, the global population of people over the age of 60 is estimated to reach 1.4 billion.

With growing age, old people get numerous health issues. The geriatric population is most vulnerable to a wide range of health problems, including osteoporosis, arthritis, vision loss, anterior cruciate ligament (ACL) sprains, and musculoskeletal conditions. Osteoarthritis (OA) is a common age-related ailment. It is frequently referred to as a degenerative disease, and many people believe it is an unavoidable consequence of ageing. Degradation and damage of articular cartilage is a key aspect of osteoarthritis. In such condition, viscosupplementation treatment delivers very effective results. Therefore, the increasing geriatric population is fueling up the demand of viscosupplementation.

However, deficit of technical expertise, interlinked side-effects i.e., inflammation, site aching, and extreme price of viscosupplementation treatment are expected to operate as key restraint to the growth of the global viscosupplementation market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global viscosupplementation market which includes company profiling of F. Hoffmann-La Roche Ltd, Chugai Pharmaceutical Co., Ltd., OrthogenRx, Inc., Sanofi-aventis Groupe, Anika Therapeutics, Inc., Seikagaku Corporation, Smith & Nephew plc, Lifecore Biomedical LLC, LG Chem Life Sciences Innovation Center, Inc., Fidia Farmaceutici S.p.A., and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global viscosupplementation market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919